Stockholders' Equity (Details) $ / shares in Units, $ in Thousands		1 Months Ended		12 Months Ended
		Sep. 30, 2021 shares	Aug. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) Vote $ / shares shares	Dec. 31, 2022 $ / shares shares	Dec. 31, 2021 shares	Oct. 27, 2023 USD ($)	Aug. 01, 2023 USD ($)	Jan. 09, 2020 $ / shares shares
Equity, Class of Treasury Stock [Line Items]
Number of votes for each common stock | Vote				1
Common Stock Par or Stated Value Per Share | $ / shares				$ 0.00001	$ 0.00001
August 2023 Repurchase Program
Equity, Class of Treasury Stock [Line Items]
Repurchase of shares of common stock approved | $								$ 125,000
Shares of common stock repurchased and retired				1,439,792
Aggregate cost of common stock repurchased and cancelled, exclusive of commissions and transaction fees | $				$ 50,000
October 2023 Repurchase Program
Equity, Class of Treasury Stock [Line Items]
Repurchase of shares of common stock approved | $							$ 200,000
Shares of common stock repurchased and retired				1,814,653
Aggregate cost of common stock repurchased and cancelled, exclusive of commissions and transaction fees | $				$ 50,000
OrbiMed Royalty & Credit Opportunities, LP.
Equity, Class of Treasury Stock [Line Items]
Purchase of common stock upon exercise of warrants									410,239
Warrants initial exercise price | $ / shares									$ 16.10
Issuance of common stock (in shares)		221,511
Common Stock
Equity, Class of Treasury Stock [Line Items]
Issuance of common stock (in shares)	[1]				8,050	1,270,462
Shares of common stock repurchased and retired	[1]			3,254,445
Common Stock | Blackstone Alternative Credit Advisors ("Blackstone")
Equity, Class of Treasury Stock [Line Items]
Number of shares sold			1,048,951
Common Stock Par or Stated Value Per Share | $ / shares			$ 0.00001
Aggregate cash consideration | $			$ 30,000
Price per share (in USD per share) | $ / shares			$ 28.60

[1] Common stock of Harmony Biosciences Holdings, Inc.